Top

Current Reviews in Musculoskeletal Medicine

Published in:

01-09-2018 | Prosthetic Joint Infection (S Nodzo and N Frisch, section editors)

Two-Stage Revision Arthroplasty for the Treatment of Prosthetic Joint Infection

Authors: Ryan S. Charette, Christopher M. Melnic

Published in: Current Reviews in Musculoskeletal Medicine | Issue 3/2018

Abstract

Purpose of Review

To review the diagnosis and treatment of prosthetic joint infection (PJI) with a focus on two-stage revision arthroplasty. The text will discuss different spacer constructs in total knee and total hip arthroplasty and will present clinical outcome data for these various options.

Recent Findings

There is no appreciable difference in infection eradication between mobile and static antibiotic spacers. Mobile spacers have shown improved knee range of motion after second-stage re-implantation.

Summary

Two-stage revision arthroplasty is the gold standard treatment for PJI. The first stage involves removal of all components, cement, and compromised soft tissues with placement of an antibiotic-impregnated spacer. Spacer options include both mobile and static spacers. Mobile spacers offer maintenance of ambulation and joint range of motion between staged procedures and have shown to be as effective in eradicating infection as static spacers.

Martinez-Cano J, Herrera-Escobar J, Arango Gutierrez A, Sanchez Vergel A, Martinez-Rondanelli A. Prospective quality of life assessment after hip and knee arthroplasty: short and mid-term follow up results. Arthroplasty Today. 2016;15:125–30.

Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;4:780–5.

Zhan C, Kaczmarek R, Loyo-Berrio N, Sangl J, Bright R. Incidence and short-term outcomes of primary and revision hip replacement in the United States. J Bone Joint Surg Am. 2007;3:526–33.CrossRef

Bozic K, Katz P, Cisternas M, Ono L, Ries M, Showstack J. Hospital resource utilization for primary and revision total hip arthroplasty. 2005, 3: 570–576.

Salvati E, Gonzalez Della Valle a, Masri B, Duncan C. The infected total hip arthroplasty. Instr Course Lect. 2003;52:223–45.PubMed

Spangehl M, Masri B, O'Connell J, Duncan C. Prospective analysis of preoperative and intraoperative. investigations for the diagnosis of infection at the sites of two hundred and. two revision total hip arthroplasties. J Bone Joint Surg Am. 1999;81(5):672–83.CrossRefPubMed

Springer B, Cahue S, Etkin C, Lewallen D, McGrory B. Infection burden in total hip and knee arthroplasties: an international registry-based perspective. Arthroplasty Today. 2017;3(2):137–40.CrossRefPubMedPubMedCentral

• Parvizi J, Gehrke T. Definition of Periprosthetic joint infection. J Arthroplast. 2014;29:1331. This article presents the Musculoskeletal Infection Society definition of both acute and chronic PJI. The article outlines the major and minor criteria for PJI as well as cutoff values for synovial WBC count, PMN%, ESR, CRP, Leukocyte esterase and histological analysis of tissue. CrossRef

Parvizi J, Zmistowski B, Berbari E, Bauer T, Springer B, Della Valle C, et al. New definition for Periprosthetic joint infection. Clin Orthop Relat Res. 2011;469:2992–4.CrossRefPubMedPubMedCentral

10.

Bedair H, Ting N, Jacovides C, Saxena a, Moric M, Parvizi J, et al. The mark Coventry award: diagnosis of early postoperative TKA infection using synovial fluid analysis. Clin Orthop Relat Res. 2011;469(1):34–40.CrossRefPubMed

11.

Trampuz A, Hanssen A, Osmon D, Mandrekar J, Steckelberg J, Patel R. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Medicine. 2004;117(8):556–62.CrossRef

12.

Schinsky M, Della Valle C, Sporer S, Paprosky W. Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty. J Bone Joint Surg Am. 2008;90(9):1869–75.CrossRefPubMed

13.

Della Valle C, Sporer S, Jacobs J, Berger R, Rosengerg A, Paprosky W. Preoperative testing for sepsis before revision total knee arthroplasty. J Arthroplast. 2007;22(6 suppl 2):90–3.CrossRef

14.

Mason J, Fehring T, Odum S, Griffin W, Nussman D. The value of white blood cell counts before revision total knee arthroplasty. J Arthroplast. 2003;18(8):1038–43.CrossRef

15.

Ghanem E, Parvizi J, Burnett R, Sharkey P, Keshavarzi N, Aggarwal A. Et. A: cell count and differential of aspirated fluid in the diagnosis of infection at the site of total knee arthroplasty. J Bone Joint Surg Am. 2008;90(8):1637–43.CrossRefPubMed

16.

•• Higuera C, Zmistowski B, Malcom T, Barsoum W, Sporer S, Mommsen P, et al. Synovial fluid cell count for diagnosis of chronic Periprosthetic hip infection. J Bone Joint Surg. 2017;99:753–9. This is a multicenter study using receiver operating characteristic curves to determine the optimal threshold values for prosthetic hip aspirate synovial WBC count and PMN %. They reported the optimal value to be 3,966 cells/μL and 80% PMN. CrossRefPubMed

17.

Parvizi J, Adeli B, Zmistowki B, Restrepo C, Greenwald A. Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection. J Bone Joint Surg Am. 2012;94(14):e104. e1-9CrossRefPubMed

18.

Segreti J, Nelson J, Trenholme G. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis. 1998;27(4):711–3.CrossRefPubMed

19.

Goulet J, Pellicci P, Brause B, Salvati E. Prolonged suppression of infection in total hip arthroplasty. J Arthroplast. 1988;3(2):109–16.CrossRef

20.

Rao N, Crosset L, Sinha R, Le Frock J. Long-term suppression of infection in total joint arthroplasty. Clin Orthop Relat Res. 2003;414:55–60.CrossRef

21.

Tsukayama D, Wicklund B, Gustilo R. Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics. 1991;14(8):841–4.PubMed

22.

Odum S, Fehring T, Lombardi A, Zmistowski B, Brown N, Luna J, et al. Periprosthetic infection consortium. Irrigation and debridement for periprosthetic infections: does the organism matter? J Arthroplast. 2011;26(6 suppl):114–8.CrossRef

23.

Bradbury T, Fehring T, Taunton M, Hanssen A, Azzam K, Parvizi J, et al. The fate of acute methicillin-resistant staphyloccocus aureus periprosthetic knee infections treated by open debridement and retention of components. J Arthroplast. 2009;24(6 suppl):103–7.

24.

Parvizi J, Pawasarat I, Azzam K, Joshi A, Hansen E, Bozic K. Periprosthetic infection due to resistant staphylococci: serious problems on the horizon. Clin Orthop Relat Res. 2009;467(7):1732–9.CrossRefPubMedPubMedCentral

25.

Sherrell J, Fehring T, Odum S, Hansen E, Zmistowki B, Dennos A, et al. The Chitranjan Ranawat award: fate of two-stage reimplantation after failed irrigation and debridement for periprosthetic knee infection. Clin Orthop Relat Res. 2011;469(1):18–25.CrossRefPubMed

26.

Canner G, Steinberg M, Heppenstall R, Balderston R. The infected hip after total hip arthroplasty. J Bone Joint Surg Am. 1984;66(9):1393–9.CrossRefPubMed

27.

Castellanos J, Flores X, Llusa M, Chiriboga C, Navarro A. The Girdleston pseudarthrosis in the treatment of infected hip replacements. Int Orthop. 1998;22(3):178–81.CrossRefPubMedPubMedCentral

28.

Grauer J, Amstutz H, O'Carroll P, Dorey F. Resection arthroplasty of the hip. J Bone Joint Surg Am. 1989;71(5):669–78.CrossRefPubMed

29.

Schroder J, Saris D, Besselaar P, Marti R. Comparison of he results of the Girdlestone pseudarthrosis with reimplantation of a total hip replacement. Int Orthop. 1998;22(4):215–8.CrossRefPubMedPubMedCentral

30.

Insall J, Thompson F, Brause B. Two-stage reimplantation for the salvage of infected total knee arthroplasty. J Bone Joint Surg Am. 1983;65:1087–98.CrossRefPubMed

31.

Garvin K, Hanssen A. Infection after total hip arthroplasty: past, present, and future. J Bone Joint Surg Am. 1995;77:1576–88.CrossRefPubMed

32.

Lu J, Han J, Zhang C, Yang Y, Yao Z. Infection after total knee arthroplasty and its gold standard surgical treatment: spacers used in two-stage revision arthroplasty. Intractable Rare Dis Res. 2017;6(4):256–61.CrossRefPubMedPubMedCentral

33.

Kalore N, Gioe T, Sing J. Diagnosis and management of infected total knee arthroplasty. Open Orthop J. 2011;5:86–91.CrossRefPubMedPubMedCentral

34.

Martinez-Pastor J, Macule-Beneyto F, Suso-Vergara S. Acute infection in total knee arthroplasty: diagnosis and treatment. Open Orthop J. 2013;7:197–204.CrossRefPubMedPubMedCentral

35.

Chun K, Kim K, Chun C. Infection following total knee arthropalsty. Knee Surg Relat Res. 2013;25:93–9.CrossRefPubMedPubMedCentral

36.

de Carvalho L, Tempon E, Badet R. Infection after total knee replacement: diagnosis and treatment. Rev Bras Orthop. 2013;24:389–96.CrossRef

37.

• Ford A, Holzmeister A, Rees H, Pelich B. Characterization of outcomes of 2-stage exchange arthroplasty in the treatment of prosthetic joint infections. J Arthroplasty. 2018; https://doi.org/10.1016/j.arth.002018.000002.000043. This is a recent review of 80 patients undergoing resection arthroplasty with placement of an antibiotic spacer for PJI at a single institution. They report lower rates of success than previously reported in the literature, including only 66 of the patients undergoing second-stage re-implantation, and 28% of these patients having persistent infection. Additionally, 30% of patients had a serious complication during their treatment course.

38.

Jacobs C, Christian C, Berend M. Static and mobile antibiotic-impregnated cement spacers for the management of prosthetic joint infection. J Am Acad Orthop Surg. 2009;17:356–8.CrossRefPubMed

39.

Jhao C, Jiang C. Two-stage reimplantation without cement spacer for septic total joint replacement. J Formos Med Assoc. 2003;102:37–41.PubMed

40.

Fehring T, Odum S, Calton T, Mason J. Articulating versus static spacers in revision total knee arthroplasty for sepsis. Clin Orthop. 2000;380:9–16.CrossRef

41.

Durbhakula S, Czajka J, Fuchs M, Uhl R. Antibiotic-loaded articulating cement spacer in the 2-stage exchange of infected total knee arthroplasty. J Arthroplasty. 2004;19:768–74.CrossRefPubMed

42.

Meek RM, Masri B, Dunlop D. et a: Patient satisfaction and functional status after treatment of infection at teh site of a total knee arthroplasty with the use of the PROSTALAC articulating spacer. J Bone Joint Surg Am. 2003;85A:1888–92.CrossRef

43.

Hart W, Jones R. Two-stage revision of infected total knee replacements using articulating cement spacers and short-term antibiotic therapy. Bone Joint J. 2006;88:1011–5.CrossRef

44.

Mazzucchelli L, Rosso F. Marmotti A, bonasia D, Bruzzone M, Rossi R: The use of spacers (static and mobile) in infection knee arthroplasty. Curr Rev. Musculoskelt Med. 2015;8:373–82.CrossRef

45.

Emerson R, Muncie M, Tarbox T, Higgins L. Comparison of a static with a mobile spacer in total knee infection. Clin Orthop Relat Res. 2002;404:132–8.CrossRef

46.

•• Voleti P, Baldwin K, Lee G. Use of static or articulating spacers for infection following knee arthroplasty: a systematic literature review. J Bone Joint Surg Am. 2013;95(17):1594–9. This article is a systematic review looking at patient outcomes after two-stage revision with either a static or an articulating spacer. There were 39 articles included in the review (Level III and IV evidence). There was no difference in re-infections rates, however there was significantly better ultimate knee range of motion after second-stage re-implantation in the articulating spacer group. Despite this, there was no difference in functional scores. CrossRefPubMed

47.

Thabe H, Schill S. Two-stage reimplantation with an application spacer and combined with delivery of antibiotics in the management of prosthetic joint infection. Oper Orthop Traumatol. 2007;19:78–100.CrossRefPubMed

48.

Hsu Y, Cheng H, Ng T, Chiu K. Antibiotic-loaded cement articulating spacer the 2-stage reimplantation in infected total knee arthropalsty: A simple and economic method. J Arthroplasty. 2007;22:1060–6.CrossRefPubMed

49.

Choi H, Malchau H, Bedar H. Are prosthetic spacers safe to use in 2-stage treatment for infected total knee arthroplasty? J Arthroplasty. 2012;27:1474–9.CrossRefPubMed

50.

Ha C. A technique for intraoperative construction of antibiotic spacers. Clin Orthop Relat Res. 2006;445:204–9.PubMed

51.

Pitto R, Castelli C, Ferrari R, Munro J. Pre-formed articulating knee spacer in two-stage revision for the infected total knee arthroplasty. Int Orthop. 2005;30:257–61.

52.

Evans R. Successful treatment of total hip and knee infection with articulating antibiotic components: A modified treatment method. Clin Orthop Relat Res. 2004;427:37–46.CrossRef

53.

Hofmann A, Kane K, Tkach T, Plaster R, Camargo M. Treatment of infected total knee arthroplasty using an articulating spacer. Clin Orthop Relat Res. 1995;321:45–54.

54.

Pietsch M, Hofmann S, Wenisch C. Treatment of deep infection of total knee arthroplasty using a two-stage procedure. Oper Orthop Traumatol. 2006;18:66–87.CrossRefPubMed

55.

Cuckler J. The infected total knee: Management options. J Arthroplasty. 2005;20(4 suppl 2):33–6.CrossRefPubMed

56.

Jamsen E, Sheng P, Halonen P. et a: Spacer prostheses in two-stage revision of infected knee arthroplasty. Int Orthop. 2006;30:257–61.CrossRefPubMedPubMedCentral

57.

Haddad F, Masri B, Campbell D, McGraw R, Beauchamp C, Duncan C. The PROSTALAC functional spacer in two-stage revision for infected knee replacements: Prosthesis of antibiotic loaded acrylic cement. J Bone Joint Surg Br. 2000;82:807–12.CrossRefPubMed

58.

Hsieh P, Shih C, Chang Y, Lee M, Shih H, Yang W. Two-stage revision hip arthroplasty for infection: Comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg Am. 2004;1989–1997.

59.

Haddad F, Muirhead-Allwood S, Manktelow A, Bacarese-Hamilton I. Two-stage uncemented revision hip arthroplasty for infection. J Bone Joint Surg Br. 2000;82:689–94.CrossRefPubMed

60.

Yamamoto K, MMiyagawa N, Masaoka T, Katori Y, Shishido T, Imakiire A. Clinical effectiveness of antibiotic-impregnated cement spacers for the treatment of infected implants of the hip. J Orthop Sci. 2003;8:823–8.CrossRefPubMed

61.

Bertazzoni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother. 2004;53:329–34.CrossRefPubMed

62.

Durbhakula S, Czaijka J, Fuchs M, Uhl R. Spacer endoprosthesis for the treatment of infected total hip arthropalsty. J Arthroplasty. 2004;19:760–74.CrossRefPubMed

63.

Barrack R. Rush pin technique for temporary antibiotic-impregnated cement prosthesis for infected total hip arthropalsty. J Arthroplasty. 2002;17:600–3.CrossRefPubMed

64.

Koo K, Yang J, Cho S. et a: Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty. J Arthroplasty. 2001;16:882–92.CrossRefPubMed

65.

Shoellner C, Fuerderer S, Rompe J, Eckardt A. Individual bone cement spacers (IBCS) for septic hip revision. Arch Orthop Trauma Surg. 2003;123:254–9.CrossRef

66.

Magnan B, Regis D, Biscaglia R, Bartolozzi P. Preformed acrylic bone cement spacer loaded with antibiotics: Use of two-stage procedure in 10 patients because of infected hips after total replacement. Acta Orthop Scand. 2001;72:591–4.CrossRefPubMed

67.

Takahira N, Itoman M, HIgashi K, Uchiyama K, Miyabe M, Naruse K. Treatment outcome of two-stage revision total hip arthroplasty using antibiotic-impregnated cement spacer. J Orthop Sci. 2003;8:26–31.CrossRefPubMed

68.

Pearle A, Sculco T. Technique for fabrication of an antibiotic-loaded cement hiarthroplasty (ANTILOCH) prosthesis for infected total hip arthroplasty. Am J Orthop. 2002;31:425–7.PubMed

69.

Hofmann A, Goldberg T, Tanner A, Cook T. Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip. J Arthroplasty. 2005;20:874–9.CrossRefPubMed

70.

Haddad F, Masri B, Garbuz D, Duncan C. The treatment of the infected hip replacement: The complex case. Clin Orthop Relat Res. 1999;369:144–56.CrossRef

71.

Wentworth S, Masri B, Duncan C, Southworth C. Hip prosthesis of antibiotic-loaded acrylic cement for the treatment of infections following total hip arthroplasty. J Bone Joint Surg Am. 2002;84(suppl 2):123–8.CrossRefPubMed

72.

Kuzyk P, Dhotar H, Sternheim A, Gross A, Safir O, Backstein D. Two-stage revision arthroplasty for management of chronic periprosthetic hip and knee infection: Techniques, Controversies and Outcomes. J Am Acad Orthop Surg. 2014;22:153–64.CrossRefPubMed

73.

Masri B, Panagiotopoulos K, Greidanus N, Garbuz D, Duncan C. Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty. J Arthroplasty. 2007;22(1):72–8.CrossRefPubMed

74.

Smilack J, Flittie W, Williams TJ. Bone concentrations of antimicrobial agents after parenteral administration. Antimicrob Agents Chemother. 1976;9(1):169–71.CrossRefPubMedPubMedCentral

75.

Hoad-Reddick D, Evans C, Norman P, Stockley I. Is there a role for extended antibiotic therapy in a two-stage revision of the infected knee arthroplasty? J Bone Joint Surg Br. 2005;87(2):171–4.CrossRefPubMed

76.

Stockley I, Mockford B, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br. 2008;90(2):145–8.CrossRefPubMed

77.

Whittaker J, Warren R, Jones R, Gregson P. Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chornic gram-positive infection? J Bone Joint Surg Br. 2009;91(1):44–51.CrossRefPubMed

78.

Hsieh P, Huang K, Lee P, Lee M. Two-stage revision of infected hip arthroplasty using an antibiotic-loaded spacer: Retrospective comparison between short-term and prolonged antibiotic therapy. J Antimicrob Chemoth. 2009;64(2):392–7.CrossRef

79.

Ghanem E, Azzam K, Seeley M, Joshi A, Parvizi J. Staged revision for knee arthroplasty infection: What is the role of serologic tests before reimplantation? Clin Orthop Relat Res. 2009;469(4):1002–8.

80.

Kusuma S, Ward J, Jacofsky M, Sporer S, Della Valle C. What is the role of serological testing between stages of two-stage reconstruction of the infected prosthetic knee? Clin Orthop Relat Res. 2011;469(4):1002–8.CrossRefPubMed

81.

Shukla S, Ward J, Jacofsky M, Sporer S, Paprosky W, Della Valle C. Perioperative testing for persistent sepsis following resectino arthroplasty of the hip for periprosthetic infection. J Arthroplasty. 2010;25(6 suppl):87–91.CrossRefPubMed

82.

Lonner J, Siliski J, Della Valle C, DiCesare P, Lotke P. Role of knee aspiration after resection of the infected total knee arthroplasty. Am J Orthop. 2001;30(4):305–9.PubMed

83.

Mont M, Waldman B, Hungerford D. Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection: A comparison-group study. J Bone Joint Surg Am. 2000;82(11):1552–7.CrossRefPubMed

84.

Della Valle C, Bogner E, Desai P, et al. Analysis of frozen sections of intraoperative specimens obtained at the time of reoperation after hip or knee resection arthroplasty for the treatment of infection. J Bone Joint Surg Am. 1999;81(5):684–9.CrossRefPubMed

85.

Bori G, Soriano A, Garcia S, Mallofre C, J R, Mensa J. Usefulness of histological analysis for predicting the presence of microorganisms at the time of reimplantation after hip resection arthroplasty for the treatment of infection. J Bone Joint Surg Am. 2007;89(6):1232–7.CrossRefPubMed

Title: Two-Stage Revision Arthroplasty for the Treatment of Prosthetic Joint Infection
Authors: Ryan S. Charette
Christopher M. Melnic
Publication date: 01-09-2018
Publisher: Springer US
Published in: Current Reviews in Musculoskeletal Medicine / Issue 3/2018
Electronic ISSN: 1935-9748
DOI: https://doi.org/10.1007/s12178-018-9495-y

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Two-Stage Revision Arthroplasty for the Treatment of Prosthetic Joint Infection

Abstract

Purpose of Review

Recent Findings

Summary

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 3/2018

The role of biologic in foot and ankle trauma—a review of the literature

Clinical and radiologic evaluation of the posterior cruciate ligament-injured knee

Limited Approaches to Calcaneal Fractures

The Role of One-Stage Exchange for Prosthetic Joint Infection

Management of Pediatric Ankle Fractures

Current Concepts in Talar Neck Fracture Management